Tag: Rivas

Rivus Pharmaceuticals Strengthens Executive Team and Board with Appointments of Tom O’Neil as Chief Financial Officer and Erin Lavelle as Director

Financial by Comments are Disabled

– Company continuing to advance clinical development of HU6, a novel oral, once-daily Controlled Metabolic Accelerator, in Phase 2 trials to treat obesity-related heart failure and metabolic dysfunction-associated steatohepatitis (MASH) – CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 11,…

Continue Reading →